Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.
Saved in:
| Title: | Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations. |
|---|---|
| Authors: | Lin YT; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Division of Hematological Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan., Tsai XC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. xavierchtsai@ntu.edu.tw., Tien FM; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Kuo YY; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan., Tseng MH; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan., Liu JH; Department of Hematology and Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan., Ko BS; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.; Department of Hematology and Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan., Cheng CL; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chou SC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin ME; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin CC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chuang MK; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Yao M; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hou HA; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. hsinanhou@ntu.edu.tw.; Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. hsinanhou@ntu.edu.tw., Chou WC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei, Taiwan. |
| Source: | Blood research [Blood Res] 2026 Jun 03; Vol. 61 (1). Date of Electronic Publication: 2026 Jun 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: Switzerland NLM ID: 101605247 Publication Model: Electronic Cited Medium: Print ISSN: 2287-979X (Print) Linking ISSN: 2287979X NLM ISO Abbreviation: Blood Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2287-979X |
|---|---|
| DOI: | 10.1007/s44313-026-00144-3 |
